View Clinical Trial (Medical Research Study)
Effectiveness of the Asthmapolis Monitoring System
| City: |
|
Woodland |
| State: |
|
California |
| Zip Code: |
|
95695 |
| Conditions: |
|
Asthma |
| Purpose: |
|
Asthmapolis is collaborating with Catholic Healthcare West (CHW) to carry out a focused
demonstration project to evaluate the effectiveness and potential cost savings of a
deployment of the Asthmapolis approach to asthma management. The Asthmapolis goal is to
bring together the best technology and asthma insight in order to provide CHW with an
engaging, data-driven chronic care program to improve asthma management and lower healthcare
utilization costs, and to respond to prevention-focused reforms to health insurance laws.
This project has been designed to implement and evaluate a data-driven program to improve
asthma management and control and lower direct costs through reductions in healthcare
utilization. This program has been developed by Asthmapolis and has gone through preliminary
testing. Each subject participating in the study will receive an Asthmapolis device, which
captures the time and location of use of inhaled short-acting bronchodilators over a
twelve-month period. This information is processed and delivered at regular intervals to the
patient and his or her provider to support improved asthma management.
The purpose of the study is to evaluate the impact of the adoption of the Asthmapolis system
into a healthcare organization, and to provide sufficient information to inform decision
making for potential future adopters. The researchers believe that the Asthmapolis system
has the potential to improve asthma control by providing rescue inhaler actuation data and
tailored asthma management tips to patients with uncontrolled asthma, and rescue inhaler
actuation data to their providers. Improvements in asthma control should be reflected in
reductions in healthcare utilization for asthma, and potentially for general healthcare
utilization. Reductions in utilization would result in lower healthcare costs. The study has
been designed to capture data on individual subject asthma control, and changes in
utilization and costs over a one-year introduction period.
|
| Study Summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Provider diagnosis of asthma (ICD9 493.xx);
- At least one healthcare utilization event in CHW within last 12 months; and
- Prescription for Short Acting Beta Agonist (SABA) at study intake.
Exclusion Criteria:
- Subject is under the age of 5 at the beginning of the study;
- Subject does not speak either English or Spanish;
- Subject does not have access to the Internet or email to receive reports; and
- Subject has substantial co-morbidity (provider diagnosis of COPD
|
| NCT ID: |
|
NCT01509183 |
| Primary Contact: |
|
Principal Investigator
Rajan K Merchant, MD
Catholic Healthcare West Medical Foundation
|
| Backup Contact: |
|
N/A |
| Location Contact: |
|
Woodland, California 95695
United States
Jesika Riley
Phone: 530-669-5633
Email: jesika.riley@asthmapolis.com
Site Status: Recruiting |
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
June 19, 2013 |
| Modifications to this listing: |
|
Only selected fields are shown, please use the link
below to view all information about this clinical trial. |
|
Click to view Full Listing
|